chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recvd Typhoid vax about 1355, had fever 102.4 in next 2-3 hrs w/chills, abd pain & vomiting; At about 1830 collapsed w/no pulse; could not be resiscitated; six other receiving same vax had no more than usual mild reactions;
Itching, rash, fever, laryngitis, pharyngitis during one wk; treatment; decadron pack, DPH, Suprax, Vita-Numonyl, seldane-D
30 minutes post vaccination, pt started feeling flushed and itchy (mostly in the anterior neck, Rside of face and R ear). Positive pruitis and flushing, vital signs taken, within normal limits for pt
Excessive high-pitched screaming, severe diarrhea requiring bathing and clothing changes up to 8 times in 24 hours, pea-sized knot at injection site that was painful to touch.
her mom after receive the second dose of adult purple cap Pfizer she got hypothyroid; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team for a Pfizer sponsored program (159558).  A 63 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, MANUFACTURER UNKNOWN), for COVID-19 Immunization. The following information was reported: HYPOTHYROIDISM (medically significant), outcome "unknown", described as "her mom after receive the second dose of adult purple cap Pfizer she got hypothyroid".  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the current limited available information and the drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of event hypothyroidism cannot be excluded.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-202200404844 same reporter/drug/event, different patients
Patient received his Moderna #2 around 9:40 AM. About 4 minutes later his wife signaled that he was in distress by honking her horn. Upon arrival to the patient, he was clutching at his throat, wheezing, and whispering he couldn't breathe. Dyspneic with respiratory rate 20-30, heart rate 60's. No hives/flushing or signs of syncope. Given significant respiratory distress, decision was made to give epinephrine IM right thigh. About 4-5 minutes after injection, patient's respiratory rate came down and he said he felt his throat open up. He was then sent to the ER, where he received Benadryl, Famotidine, Methylprednisone, and Albuterol/Atrovent nebulizer. Pt sent home at 1PM, after 3 hours of observation. Pt is still doing well via phone follow up 24 hours after event.
arm still sore since 26-02-2021, two days after he got his first vaccine; shoulder sore since 26-02-2021, two days after he got his vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm still sore since 26-02-2021, two days after he got his first vaccine) and ARTHRALGIA (shoulder sore since 26-02-2021, two days after he got his vaccine.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm still sore since 26-02-2021, two days after he got his first vaccine) and ARTHRALGIA (shoulder sore since 26-02-2021, two days after he got his vaccine.). At the time of the report, PAIN IN EXTREMITY (arm still sore since 26-02-2021, two days after he got his first vaccine) and ARTHRALGIA (shoulder sore since 26-02-2021, two days after he got his vaccine.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow-up information  received on 03-May-2021 contains non-significant information.
As of 4/18 called reported breaking out in hives on her shoulders, which she's never had before in her life, but got better after taking Benadryl. She is still itchy and knows that she has hives from her head to her toes and is feeling better today but wanted to report the effects.
In the patient's own words: "Initially I had a sore shoulder. Subsequently, soreness would come and go randomly. And that would be once a week. May last 2 hours or 15 minutes - no pattern. And the soreness is in the same exact spot  as the injection soreness. Within the last two months, random movement of my arm creates severe pain at the injection site and my arm becomes incapacitated. It can last 5 minutes or it can last an hour. Usually followed by achiness. Now it's getting worse and that's what's prompting this."
This spontaneous case was reported by a health care professional and describes the occurrence of NECK MASS (Rash and two bumps on the left side of Neck), PAIN IN EXTREMITY (Sore Arm), RASH (Rash and two bumps on the left side of Neck), PYREXIA (hot body temperature) and HEADACHE (very bad headache) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in April 2020. On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). On 26-Feb-2021, the patient experienced NECK MASS (Rash and two bumps on the left side of Neck) and RASH (Rash and two bumps on the left side of Neck). On 27-Feb-2021, the patient experienced HEADACHE (very bad headache). On 01-Mar-2021, the patient experienced PYREXIA (hot body temperature) and CHILLS (chills). On 02-Mar-2021, the patient experienced NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) on 23-Feb-2021 for Pain in arm, at a dose of 1 dosage form and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 26-Feb-2021 for Rash and Neck mass, at a dose of 1 dosage form. On 24-Feb-2021, PAIN IN EXTREMITY (Sore Arm) outcome was unknown. On 27-Feb-2021, NECK MASS (Rash and two bumps on the left side of Neck) and RASH (Rash and two bumps on the left side of Neck) had resolved, HEADACHE (very bad headache) outcome was unknown. At the time of the report, PYREXIA (hot body temperature), CHILLS (chills) and NAUSEA (Nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment medications include Tylenol for headache. Patient gave consent to safety for Follow-up.
felt dizzy, dec vision & hearing-c/o feeling cold all AM;slid to floor w/o striking  anything;BP 110/70, HR78;vasovagal response to MMR vax;T102, malaise;
This is a spontaneous report from a contactable pediatrician. A 20 year-old female patient received the first dose of TRUMENBA intramuscular on 27Jun2016 at 0.5 ml single. No relevant medical history was reported, there were not concomitant medications. On 27Jun2016, 30 seconds after having received the vaccine, the patient experienced generalised seizure. She underwent laboratory tests and procedures which included computerised tomogram of the brain with normal result on 27Jun2016. The patient completely recovered on an unspecified date in Jun2016 without any treatment. The reporter believed that generalized seizure was related to TRUMENBA, he added there were no other vaccines given at the time and the patient was otherwise a healthy patient.
Patient stated they got their vaccination in their left arm.  Two days later they woke up and they had a red rash dispersed on the injection site going down towards their elbow.  Patient stated it felt warm to the touch.  Had patient contact their primary care doctor in which they were given Triamincolone and Keflex.
Client received vaccines on 7/15/19 at around 200 pm pt showed no s/s of an allergic reactions. stated feels fine. per mom pt complained of slight HA on 7/15/19, continued with HA on 7/16/19. On 7/17/19 at about 1130 am pt c/o tingling/numbness to (R) Foot radiating to (R) extremity, then LLE. and continued to upper body and upper (B) extremities. Episode happened for 5 minutes x 1. pt states feels fine today.
Patient had fevers that reached 104.6 on 1/20/23. I gave Tylenol and alternated Motrin 5ml. Fever would still not subside even with fever reducer. (Still 104.1) By 5:30pm on 1/20/23 I left message for a medical assistant because fever reducer was not working and my child was uncomfortable and crying non stop.
Expired Vaccine Injected to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Injected to patient) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No Medical History information was reported.   In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jun-2021 at 9:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Injected to patient). On 08-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Injected to patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication and treatment information were not reported.
cannot even use my arm; arm hurts so bad / painful injection; I want to cry; can't sleep.; This case was reported by a consumer and described the occurrence of injected limb mobility decreased in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th July 2020, the patient received the 1st dose of Shingrix. On 15th July 2020, less than a day after receiving Shingrix, the patient experienced injected limb mobility decreased, pain in arm, crying and insomnia. On an unknown date, the outcome of the injected limb mobility decreased, pain in arm, crying and insomnia were not recovered/not resolved.   It was unknown if the reporter considered the injected limb mobility decreased, pain in arm, crying and insomnia to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient received Shingrix and was very painful injection and arm hurts so bad that want to cry. The patient cannot even use arm and cannot sleep.  The pain mention in list of side effects was very downplayed.
PATIENT CAME IN TO RECIEVE A SHINGLES VACCINE.  HE RECIEVED FLU VACCINE INSTEAD.  HE HAD ALREADY HAD THE FLU VACCINE ON 9-29-2021
mild swelling, and redness, no itching at the site of injection.  It got bigger overnight, but presently not getting worse today. Affected area is 4 inches x 2 inches in size.
An unapproved second booster was given to this patient.  We did not have guidance from CDC or Health Department yet and this dose should not have been given
Two days post vax, pt developed an injection site reaction measuring 7cm by 7cm and characterized by induration and erythema.
Dizziness, nausea, vomiting, weakness, shortness of breath, elevated D dimer.
Case number PHEH2014US022800 is an initial spontaneous report received from a consumer on 10 Nov 2014. This report refers to a female patient whose identifiers were not reported. Her medical history and concomitant medications were not reported. She was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on an unknown date. It was reported that on an unknown date after vaccination, she was still paralyzed on her side. The final outcome of event was unknown. The seriousness of paralysis was not reported, but the event was upgraded as medically significant based on the information available on NVS-IME list and NVx key event list. The causality of the event was not reported.
Everywhere I had arthritis hurt. Also, very tired 2nd day after and the appearance of a red rash surrounding injection site. Felt fine and rash gone by 3rd day.
Tiredness after the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness after the 1st dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tiredness after the 1st dose). At the time of the report, FATIGUE (Tiredness after the 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
57 yo with allergies to shellfish, iodine and limonene flavor which causes SOB; pregabalin and budesonide (itching) and arformoterol (rash) presented for 2nd Covid 19 vaccination.  With first vaccination on 3/11/21, she reported lip and mouth tingling approximately 15 minutes after the vaccine administration and spontaneous resolution approximately within 40 minutes without intervention.  She did not pre-medicate with antihistamines prior to 2nd Covid19 vaccination.  Dose was given in left deltoid at 0956 3/30 (lot # ER8733).  She was observed for 30 minutes after vaccine administration.  As she was preparing to leave the obs area, she reported new onset generalized pruritis.  NP assessed and found this was a
headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 30-Apr-2021 and was forwarded to Moderna on 30-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced HEADACHE (headache). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN N) for Headache, at a dose of 1 dosage form. At the time of the report, HEADACHE (headache) outcome was unknown.            No concomitant medications were reported.  Aspirin used as a treatment information
side of her face went numb; she woke up and felt funny; wanted to say but the words would not come out right; feel dizzy and faint; Initial information received on 16-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 25 years old female patient who experienced side of her face went numb (hypoaesthesia), feel dizzy and faint (dizziness), she woke up and felt funny (feeling abnormal) and wanted to say but the words would not come out right (dysarthria), while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No concomitant therapies were reported.  In January 2019, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient experienced a non-serious side of her face went numb (hypoaesthesia), feel dizzy and faint (dizziness), she woke up and felt funny (feeling abnormal) and wanted to say but the words would not come out right (dysarthria), unknown latency, following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  (Other relevant tests included no lab data.)  Final diagnosis was wanted to say but the words would not come out right, she woke up and felt funny, feel dizzy and faint and side of her face went numb.   It was not reported if the patient received a corrective treatment. The patient sat with her head between her legs for a couple of minutes and she felt better  The patient outcome is reported as Unknown for side of her face went numb, she woke up and felt funny and for wanted to say but the words would not come out right and as recovering for feel dizzy and faint.  List of document held: none; Sender's Comments: This case involves a 25 years old female patient who experienced syncope, numbness in face and dizziness after vaccination. Exact time to onset was unknown. More details regarding patient's medical history, previous vaccination history, history of similar episode, etiological workup and investigation reports to identify alternative etiology are needed for complete assessment of the case. Based on the available information the role of vaccine cannot be assessed
I experienced throat congestion:a feeling of thickness and swelling.; I experienced throat congestion:a feeling of thickness and swelling.; higher temp; arm ache; This is a spontaneous report from a contactable consumer for herself. A 79-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection) on 30Jan2021 14:30 (Lot number: EL9264) via an unspecified route of administration in the right arm at single dose for COVID-19 Immunization. The patient's medical history included cholesterol but not high. The patient had no known allergies to medications, food, or other products. The patients concomitant medication included rosuvastatin at 5mg, aspirin (acetylsalicylic acid) at 81mg. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with Covid-19 prior to vaccination and was not tested after the vaccination for COVID-19. The dose was received at 2:25pm. The dose was received on adverse event start date: 30Jan2021 at 2:25pm. patient waited the 15 minutes waiting period & went home. 95 minutes after (30Jan2021 16:00 PM) the injection she experienced throat congestion: a feeling of thickness and swelling. The symptoms lasted 35 minutes. Other reactions were normal: higher temp & arm ache. There was no treatment received for the adverse events. The outcome of the events was recovered on 30Jan2021 16:35.  No follow-up attempts are possible. No further information is expected.
Nausea; Aches; Chills; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Other HCP). The reporter is the patient.  A 69 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 14Jul2021 15:00 (Lot number: EWO196) at the age of 69 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Covid-19", start date: 2021 (unspecified if ongoing), notes: if covid prior vaccination Yes. Concomitant medication(s) included: LANSOPRAZOLE; TRAMADOLE; TYLENOL. Past drug history included: Bacitracin ointment, reaction(s): "Allergy: Bacitracin ointment", notes: Bacitracin ointment; Ciprofloxin, reaction(s): "Allergy: Ciprofloxacin", notes: Ciprofloxacin. Vaccination history included: Bnt162b2 (product=COVID 19, brand=Pfizer,, lot number=EWO191,, administration time=04:45 PM,, dose number=1,, vaccine location=Left arm), administration date: 23Jun2021, when the patient was 69 years old, for Covid-19 immunization. The following information was reported: NAUSEA (non-serious) with onset 15Jul2021 04:00, outcome "recovering", described as "Nausea"; PAIN (non-serious) with onset 15Jul2021 04:00, outcome "recovering", described as "Aches"; CHILLS (non-serious) with onset 15Jul2021 04:00, outcome "recovering", described as "Chills". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of nausea, pain, chills.   Additional Information: It was reported that not a Serious, Seriousness criteria-Results in death, Seriousness criteria-Life threatening, Seriousness criteria-Caused/prolonged hospitalization, Seriousness criteria-Disabling/Incapacitating, Seriousness criteria-Congenital anomaly/birth defect. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. List of any other medications the patient received within 2 weeks of vaccination was reported as lansoprazole; tramadole; tylenol; vitamins supple. Injection not given by this office. The patient did not provide information to you regarding the reported adverse events(s) with the use of the product.  No follow-up attempts are possible. No further information is expected.
Within four hours of vaccine, he had a fever of 102.5. The next day, his tonsils were swollen with white spots in addition to the fever. That night, he began vomiting. Two days later, his fever spiked to 105.1 in the middle of the day. Until he was admitted, we were using tylenol/Motrin for his fever. On day three he was given amoxicillin for strep, even though the strep test came back negative. Day four he was admitted to the hostpital. During the stay at the hospital, he was given a IV fluids, a variety of antibiotics, rocephin, and decadron (sp?) to reduce the swelling of his tonsils. The medical records received on 1/28/04 states dehydration.
At site of injection I developed a 6mm round area that was warm, inflamed, with a nodule like area beneath the skin, (I also received the flu vaccine the same day in my right arm, without a reaction) that was too painful to sleep on for 3 days. I ran a low-grade temperature of 100.3 -100.6 for three days. Cool compresses, topical ointments were ineffective in decreasing the swelling and itching. One week post injection the redness and erythema is gone but appears red/purple and the nodule can still be palpated. As an infant I was hospitalized at 6 months and one year with pneumonia. On 10/30/2017 my PCP prescribed a 4 mg MEDROL dosepak.
Patient received her first vaccine Thursday, March 11 and noticed on Monday (4 days later) the injection site and down her upper arm became warm, itchy, red, and swollen.  She used hydrocortisone cream starting Tuesday to relieve symptoms  and it was resolved 2 days later on Thursday.
This spontaneous report was received from a physician via office manager refers to a patient of unknown age. On 23-APR-2013, the patient was vaccinated with a dose of GARDASIL (lot # H020002, expiry date 08-AUG-2015), with the same lot of improperly stored GARDASIL. Concomitant medications were not reported. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.